文献速递免疫规划妇幼与学校卫生

早期麻疹疫苗接种对发病率与生长的影响:几内亚比绍的一项随机试验

The effect of early measles vaccination on morbidity and growth: A randomised trial from Guinea-Bissau.
PubMed 文献 · Vaccine · 2020-02-13

在麻疹疫苗对死亡率影响的试验中,3548名儿童随机分为4.5月龄+9月龄接种或仅9月龄接种,评估早期麻疹疫苗对就诊率和生长的影响。早期麻疹疫苗对MUAC-for-age、weight-for-age及就诊率无总体影响,但暴露于口服脊灰疫苗运动后就诊率降低,且疫苗效应在OPV运动前后存在交互作用。

要点

  • 早期麻疹疫苗对9月龄内生长指标和就诊率无总体影响。
  • 暴露于OPV运动后儿童就诊率降低(HR=0.81)。
  • 麻疹疫苗效应在OPV运动前后存在交互作用(p=0.03)。

核心结论

  • 早期麻疹疫苗对入组至9月龄期间的就诊率和生长无总体影响。
  • 早期麻疹疫苗对随后暴露于OPV运动的儿童似乎有有益效应。
  • 由于有益效应仅在亚组中观察到,结果应谨慎解读。

研究设计与样本

  • 在麻疹疫苗对死亡率影响的试验中,儿童随机分配至4.5月龄+9月龄接种麻疹疫苗或按推荐9月龄接种。
  • 2012年至2015年间共纳入3548名儿童。
  • 在入组和9月龄时测量上臂中围和体重,每月家访登记就诊情况。
  • 使用WHO生长参考计算年龄别体重和年龄别MUAC的Z评分,采用线性回归比较组间差异。
  • 采用Cox比例风险模型比较入组至9月龄期间的就诊率,提供早期麻疹疫苗对比无早期麻疹疫苗的就诊风险比。

主要发现

  • 早期麻疹疫苗对年龄别MUAC无影响(均值差-0.01,95%CI -0.06至0.04)。
  • 早期麻疹疫苗对年龄别体重无影响(均值差-0.03,95%CI -0.07至0.02)。
  • 早期麻疹疫苗对就诊率无影响(HR=1.03,95%CI 0.92-1.16)。
  • 暴露于OPV运动后入组儿童的就诊率较低(HR=0.81,95%CI 0.71-0.92)。
  • 麻疹疫苗效应在OPV运动暴露前(HR=1.12,95%CI 0.98-1.29)与暴露后(HR=0.83,95%CI 0.67-1.03)不同(交互作用检验p=0.03)。

局限性

  • 由于有益效应仅在亚组中观察到,结果应谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Measles vaccine (MV) has beneficial non-specific effects protecting against non-measles infections in some situations. Within a trial of the effect of MV on mortality, we assessed effects of early MV on the secondary outcomes consultations and growth, overall, and by sex and exposure to campaigns with oral polio vaccine (OPV). MATERIALS AND METHODS: Children were randomly assigned to MV at 4.5 + 9 months or MV at 9 months as recommended. At enrolment and 9 months children had their mid-upper-arm-circumference (MUAC) and weight measured. Consultations (out/inpatient) were registered at monthly home visits. Weight-for-age and MUAC-for-age Z-scores were obtained using the WHO growth reference and compared by group in linear regression models. Consultation rates between enrolment and 9 months were compared in Cox proportional hazards models, providing consultation Hazard Ratios (HRs) for early MV versus no early MV. We tested whether the effect of early MV was modified by OPV campaigns by splitting observation time at exposure to OPV campaigns. RESULTS: Among 3548 children enrolled between 2012 and 2015, early MV had no effect on MUAC-for-age (mean difference comparing early MV vs. no MV -0.01, 95% CI -0.06-0.04), weight-for-age (mean difference -0.03, 95% CI -0.07-0.02) or rates of consultations (HR = 1.03, 95% CI 0.92-1.16). The rate of consultations for children enrolled was lower after exposure to OPV campaigns (HR = 0.81, 95% CI 0.71-0.92). The effect of MV differed before exposure to OPV campaigns (HR = 1.12, 95% CI 0.98-1.29) and after OPV campaigns (HR = 0.83, 95% CI 0.67-1.03) (test for interaction: p = 0.03). Associations did not differ by sex. CONCLUSION: Early MV had no overall effect on consultation rates and growth between enrolment and 9 months of age. However, early MV tended to have beneficial effects for children subsequently exposed to OPV campaigns. As beneficial effects were observed in subgroups, the results should be interpreted with caution. CLINICAL TRIALS REGISTRATION: NCT01644721.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Steiniche MM, Thysen SM, Jensen AKG, et al. The effect of early measles vaccination on morbidity and growth: A randomised trial from Guinea-Bissau. Vaccine. 2020. PMID: 32061387. doi:10.1016/j.vaccine.2020.01.096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。